NOACs May Be Better Choice for Patients With A-Fib and DM
Risks for diabetes complications, mortality lower with non-vitamin K antagonist oral anticoagulants versus warfarin
Risks for diabetes complications, mortality lower with non-vitamin K antagonist oral anticoagulants versus warfarin
Evidence currently inadequate for assessing the balance of benefits and harms of screening for atrial fibrillation in asymptomatic adults
Risk appeared to be greater in trials testing >1 g/day dosing
The analysis included 49,357 patients undergoing LAAO procedures with the Watchman Left Atrial Appendage Closure device.
Improved communication with patients about cost, bleeding, and monitoring may increase compliance
AF episodes also linked to higher odds of peak blood alcohol concentration, total area under curve of alcohol exposure
Findings may help with decision-making in this high-risk patient population.
The Amulet device is designed for complete immediate closure of the left atrial appendage using dual-seal technology.
Disparities seen among VA patients both for initiating any anticoagulant therapy and for initiating direct-acting oral anticoagulant use
Apixaban the only direct oral anticoagulant linked to lower adverse event rates than warfarin for patients with atrial fibrillation across frailty levels